Technical Analysis for TBIO - Telesis Bio, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 20 DMA | Bearish | 5.75% | |
| Wide Bands | Range Expansion | 5.75% | |
| 20 DMA Support | Bullish | -3.02% | |
| Doji - Bearish? | Reversal | -3.02% | |
| Wide Bands | Range Expansion | -3.02% | |
| Gapped Up | Strength | -3.02% | |
| Crossed Above 20 DMA | Bullish | -0.26% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 10 hours ago |
| 20 DMA Resistance | about 10 hours ago |
| 2x Volume Pace | about 10 hours ago |
| 1.5x Volume Pace | about 10 hours ago |
| Up 5% | about 10 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 08/08/2024
Telesis Bio, Inc. Description
Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development, and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Molecular Biology Gene Expression Synthetic Biology Molecular Genetics Messenger RNA
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 31.5 |
| 52 Week Low | 3.025 |
| Average Volume | 35,477 |
| 200-Day Moving Average | 8.73 |
| 50-Day Moving Average | 4.55 |
| 20-Day Moving Average | 3.84 |
| 10-Day Moving Average | 3.74 |
| Average True Range | 0.62 |
| RSI (14) | 47.92 |
| ADX | 21.05 |
| +DI | 19.32 |
| -DI | 15.21 |
| Chandelier Exit (Long, 3 ATRs) | 3.55 |
| Chandelier Exit (Short, 3 ATRs) | 4.87 |
| Upper Bollinger Bands | 4.67 |
| Lower Bollinger Band | 3.01 |
| Percent B (%b) | 0.51 |
| BandWidth | 43.29 |
| MACD Line | -0.21 |
| MACD Signal Line | -0.28 |
| MACD Histogram | 0.0702 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.03 | ||||
| Resistance 3 (R3) | 5.07 | 4.71 | 4.84 | ||
| Resistance 2 (R2) | 4.71 | 4.42 | 4.70 | 4.77 | |
| Resistance 1 (R1) | 4.29 | 4.23 | 4.50 | 4.25 | 4.70 |
| Pivot Point | 3.93 | 3.93 | 4.04 | 3.92 | 3.93 |
| Support 1 (S1) | 3.51 | 3.64 | 3.72 | 3.47 | 3.02 |
| Support 2 (S2) | 3.15 | 3.45 | 3.14 | 2.95 | |
| Support 3 (S3) | 2.73 | 3.15 | 2.89 | ||
| Support 4 (S4) | 2.69 |
